BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 37247905)

  • 1. Stereotactic Radiotherapy or Whole-Brain Irradiation Plus Simultaneous Integrated Boost After Resection of Brain Metastases.
    Rades D; Johannwerner L; Yu NY; Gliemroth J
    Anticancer Res; 2023 Jun; 43(6):2763-2770. PubMed ID: 37247905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A matched-pair study comparing whole-brain irradiation alone to radiosurgery or fractionated stereotactic radiotherapy alone in patients irradiated for up to three brain metastases.
    Rades D; Janssen S; Dziggel L; Blanck O; Bajrovic A; Veninga T; Schild SE
    BMC Cancer; 2017 Jan; 17(1):30. PubMed ID: 28061768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single brain metastasis: resection followed by whole-brain irradiation and a boost to the metastatic site compared to whole-brain irradiation plus radiosurgery.
    Rades D; Kueter JD; Meyners T; Pluemer A; Veninga T; Gliemroth J; Schild SE
    Clin Neurol Neurosurg; 2012 May; 114(4):326-30. PubMed ID: 22152784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resection plus whole-brain irradiation versus resection plus whole-brain irradiation plus boost for the treatment of single brain metastasis.
    Rades D; Kueter JD; Gliemroth J; Veninga T; Pluemer A; Schild SE
    Strahlenther Onkol; 2012 Feb; 188(2):143-7. PubMed ID: 22234538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Cavity Irradiation or Whole-Brain Radiotherapy Following Brain Metastases Resection-Outcome, Prognostic Factors, and Recurrence Patterns.
    El Shafie RA; Dresel T; Weber D; Schmitt D; Lang K; König L; Höne S; Forster T; von Nettelbladt B; Eichkorn T; Adeberg S; Debus J; Rieken S; Bernhardt D
    Front Oncol; 2020; 10():693. PubMed ID: 32477942
    [No Abstract]   [Full Text] [Related]  

  • 7. Stereotactic radiosurgery alone versus resection plus whole-brain radiotherapy for 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Bohlen G; Pluemer A; Veninga T; Hanssens P; Dunst J; Schild SE
    Cancer; 2007 Jun; 109(12):2515-21. PubMed ID: 17487853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-brain Radiotherapy With or Without a Simultaneous Integrated Boost for Treatment of Brain Metastases.
    Rades D; Johannwerner L; Werner EM; Cremers F; Gliemroth J; Yu NY
    Anticancer Res; 2023 Jul; 43(7):3107-3112. PubMed ID: 37351983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A matched-pair analysis comparing whole-brain radiotherapy plus stereotactic radiosurgery versus surgery plus whole-brain radiotherapy and a boost to the metastatic site for one or two brain metastases.
    Rades D; Kueter JD; Pluemer A; Veninga T; Schild SE
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1077-81. PubMed ID: 18707817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
    Rades D; Kueter JD; Hornung D; Veninga T; Hanssens P; Schild SE; Dunst J
    Strahlenther Onkol; 2008 Dec; 184(12):655-62. PubMed ID: 19107346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
    Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK; Shu HK; Crocker I
    J Neurooncol; 2014 Dec; 120(3):657-63. PubMed ID: 25189789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients.
    Rades D; Pluemer A; Veninga T; Dunst J; Schild SE
    Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of linac-based fractionated stereotactic radiotherapy and stereotactic radiosurgery for patients with up to ten brain metastases.
    Hirata M; Yasui K; Oota N; Ogawa H; Onoe T; Maki S; Ito Y; Hayashi K; Asakura H; Murayama S; Mitsuya K; Deguchi S; Nakamura K; Hayashi N; Nishimura T; Harada H
    Radiat Oncol; 2022 Dec; 17(1):213. PubMed ID: 36578021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single brain metastasis: whole-brain irradiation plus either radiosurgery or neurosurgical resection.
    Rades D; Veninga T; Hornung D; Wittkugel O; Schild SE; Gliemroth J
    Cancer; 2012 Feb; 118(4):1138-44. PubMed ID: 21761403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of patients with ≥4 brain metastases using stereotactic radiosurgery boost after whole brain irradiation.
    Dincoglan F; Sager O; Gamsiz H; Uysal B; Demiral S; Oysul K; Sirin S; Caglan A; Beyzadeoglu M
    Tumori; 2014; 100(3):302-6. PubMed ID: 25076242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting the Risk of Developing New Cerebral Lesions After Stereotactic Radiosurgery or Fractionated Stereotactic Radiotherapy for Brain Metastases from Renal Cell Carcinoma.
    Rades D; Dziggel L; Blanck O; Gebauer N; Bartscht T; Schild SE
    Anticancer Res; 2018 May; 38(5):2973-2976. PubMed ID: 29715126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of regular magnetic resonance imaging follow-up after stereotactic radiotherapy to the surgical cavity in patients with one to three brain metastases.
    Bachmann N; Leiser D; Ermis E; Vulcu S; Schucht P; Raabe A; Aebersold DM; Herrmann E
    Radiat Oncol; 2019 Mar; 14(1):45. PubMed ID: 30871597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised prospective phase II trial in multiple brain metastases comparing outcomes between hippocampal avoidance whole brain radiotherapy with or without simultaneous integrated boost: HA-SIB-WBRT study protocol.
    Chia BSH; Leong JY; Ong ALK; Lim C; Poon SH; Chua MLK; Chua KLM; Kusumawidjaja G; Chua ET; Wong FY; Lee TS
    BMC Cancer; 2020 Oct; 20(1):1045. PubMed ID: 33126867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO).
    Rogers S; Baumert B; Blanck O; Böhmer D; Boström J; Engenhart-Cabillic R; Ermis E; Exner S; Guckenberger M; Habermehl D; Hemmatazad H; Henke G; Lohaus F; Lux S; Mai S; Minasch D; Rezazadeh A; Steffal C; Temming S; Wittig A; Zweifel C; Riesterer O; Combs SE
    Strahlenther Onkol; 2022 Oct; 198(10):919-925. PubMed ID: 36006436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.